(VIANEWS) – PIMCO Municipal Income Fund (PMF), GlaxoSmithKline (GSK), Avista Corporation (AVA) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. PIMCO Municipal Income Fund (PMF)

108% Payout Ratio

PIMCO Municipal Income Fund is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC.

Volume

Today’s last reported volume for PIMCO Municipal Income Fund is 23422, 35.69% below its average volume of 36426.

According to Morningstar, Inc., the next dividend payment is on Jul 8, 2021, the estimated forward annual dividend rate is 0.65 and the estimated forward annual dividend yield is 4.33%.

Year-on-year quarterly revenue growth declined by 10.8%, now sitting on 24.46M for the twelve trailing months.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.38%.

Volatility

PIMCO Municipal Income Fund’s last day, week, and month’s current volatility was 0.56%, 0.65%, and 0.65%, respectively.

PIMCO Municipal Income Fund’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.12% (day), 1.21% (last week), and 1.21% (last month), respectively.

PIMCO Municipal Income Fund’s Stock Yearly Top and Bottom Value

PIMCO Municipal Income Fund’s stock is valued at $14.50 at 13:23 EST, under its 52-week high of $15.50 and higher than its 52-week low of $13.32.

PIMCO Municipal Income Fund’s Moving Average

PIMCO Municipal Income Fund’s worth is under its 50-day moving average of $14.64 and under its 200-day moving average of $14.85.

2. GlaxoSmithKline (GSK)

76.6% Payout Ratio

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.

Volume

Today’s last reported volume for GlaxoSmithKline is 1552390, 60.91% below its average volume of 3971620.

As maintained by Morningstar, Inc., the next dividend payment is on May 19, 2021, the estimated forward annual dividend rate is 2.17 and the estimated forward annual dividend yield is 5.41%.

GlaxoSmithKline’s sales growth this year is anticipated to be 5% and 5.5% for next year.

Year-on-year quarterly revenue growth declined by 18.4%, now sitting on 32.43B for the twelve trailing months.

GlaxoSmithKline’s sales growth is 7.9% for the current quarter and 6.6% for the next. The company’s growth estimates for the present quarter and the next is negative 14% and negative -1.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.04%.

Volatility

GlaxoSmithKline’s last day, week, and month’s current volatility was 1.68%, 1.25%, and 1.03%, respectively.

GlaxoSmithKline’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.87% (day), 1.16% (last week), and 1.13% (last month), respectively.

GlaxoSmithKline’s Stock Yearly Top and Bottom Value

GlaxoSmithKline’s stock is valued at $42.80 at 13:23 EST, below its 52-week high of $43.61 and way higher than its 52-week low of $33.53.

GlaxoSmithKline’s Moving Average

GlaxoSmithKline’s value is above its 50-day moving average of $39.76 and above its 200-day moving average of $39.74.

Previous days news about GlaxoSmithKline (GSK)

  • According to Bloomberg Quint on Thursday, 4 November, "In 2018, Novartis CEO Narasimhan shed the company’s share in a consumer-health joint venture with GlaxoSmithKline Plc to focus more on innovative medicines — and internally, he axed one-fifth of Novartis’s research projects to narrow the focus to what’s most likely to succeed."
  • According to Benzinga on Monday, 8 November, "She subsequently transitioned to GlaxoSmithKline PLC where she spent 19 years and rose in the commercial ranks from a sales representative to become a Senior Vice President, Business Unit Head for the Cardiovascular, Metabolic, and Urology franchises in 2009. "

3. Avista Corporation (AVA)

74.67% Payout Ratio

Avista Corporation operates as an electric and natural gas utility company.

Volume

Today’s last reported volume for Avista Corporation is 355497, 22.09% below its average volume of 456328.

According to Morningstar, Inc., the next dividend payment is on Nov 17, 2021, the estimated forward annual dividend rate is 1.69 and the estimated forward annual dividend yield is 4.19%.

Avista Corporation’s sales growth this year is anticipated to be 8.2% and 4.8% for next year.

Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 1.39B for the twelve trailing months.

Avista Corporation’s sales growth is 13.2% for the current quarter and 5.6% for the next. The company’s growth estimates for the current quarter and the next is negative 16.5% and 4.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.6%.

Volatility

Avista Corporation’s last day, week, and month’s current volatility was 1.18%, 1.41%, and 1.43%, respectively.

Avista Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.19% (day), 2.66% (last week), and 2.63% (last month), respectively.

Avista Corporation’s Stock Yearly Top and Bottom Value

Avista Corporation’s stock is valued at $39.82 at 13:23 EST, way under its 52-week high of $49.14 and way above its 52-week low of $36.09.

Avista Corporation’s Moving Average

Avista Corporation’s worth is under its 50-day moving average of $39.83 and below its 200-day moving average of $42.73.

4. Horace Mann Educators Corporation (HMN)

34.45% Payout Ratio

Horace Mann Educators Corporation, together with its subsidiaries, operates as a multiline insurance company in the United States.

Volume

Today’s last reported volume for Horace Mann Educators Corporation is 9808, 93.02% below its average volume of 140546.

As claimed by Morningstar, Inc., the next dividend payment is on Sep 14, 2021, the estimated forward annual dividend rate is 1.24 and the estimated forward annual dividend yield is 3.06%.

Horace Mann Educators Corporation’s sales growth this year is expected to be 1.3% and 5.2% for next year.

Year-on-year quarterly revenue growth declined by 2.2%, now sitting on 1.35B for the twelve trailing months.

Horace Mann Educators Corporation’s sales growth is negative 6.5% for the present quarter and 6.7% for the next. The company’s growth estimates for the ongoing quarter and the next is negative 32.7% and negative -14.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.55%.

Volatility

Horace Mann Educators Corporation’s last day, week, and month’s current volatility was 0.40%, 2.24%, and 1.49%, respectively.

Horace Mann Educators Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.95% (day), 3.61% (last week), and 2.42% (last month), respectively.

Horace Mann Educators Corporation’s Stock Yearly Top and Bottom Value

Horace Mann Educators Corporation’s stock is valued at $40.21 at 13:23 EST, way below its 52-week high of $44.74 and higher than its 52-week low of $36.59.

Horace Mann Educators Corporation’s Moving Average

Horace Mann Educators Corporation’s worth is above its 50-day moving average of $40.03 and above its 200-day moving average of $39.57.

LEAVE A REPLY

Please enter your comment!
Please enter your name here